Medera
- Biotech or pharma, therapeutic R&D
Medera (www.medera.bio) is a clinical-stage biopharmaceutical company focused on difficult-to-treat cardiovascular diseases through next-generation AAV gene therapy. Our proprietary intracoronary delivery technology allows for a short procedure in an outpatient setting, favorable safety with no immunogenicity and other toxicities, >90% transduction in the heart, and significantly lower costs compared to other gene therapies.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}